DEFER, FAME, FAME II data have long shown the benefit of treating patients based on physiology. DEFINE FLAIR and iFR Swedeheart furthered physiology adoption with hyperemia-free measurements (iFR) and showed positive clinical outcomes, increased patient comfort and decreased procedural time.^1,2  These results have spurred new interest in resting indices and looking to what is next for physiology.

This discussion consists of four short segments:

1. Using physiology in evidence based practice
2. Using iFR or FFR in practice
3. Standards of evidence for physiological indices
4. Advancing physiology from decision to guidance

Moderator:

Ajay Kirtane, MD 
Columbia University Medical Center, New York, USA

 

Panelists:

Rasha Al-Lamee, MD 
Imperial College Healthcare NHS Trust, London, UK

Hitoshi Matsuo, MD
Gifu Heart Center, Gifu, Japan

Javier Escaned, MD
Hospital Clínico San Carlos, Madrid, Spain

---

Supported by: 

 

Learn more: 
Philips iFR Outcome data 
Philips iFR Co-registration 

---

^{1.    Davies JE, et al., Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834. 
2.    Gotberg M, et al., iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813-18233.}